Join to View Full Profile
435 E 70th StApartment 11FNew York, NY 10021
Phone+1 212-933-4627
Dr. Ruisi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2008 - 2011
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2005 - 2008
- Icahn School of Medicine at Mount SinaiClass of 2005
Certifications & Licensure
- MA State Medical License 2018 - 2026
- NJ State Medical License 2012 - 2025
- NY State Medical License 2006 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 13 citationsAvelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial.David M Loeb, Ji Won Lee, Daniel A Morgenstern, Yvan Samson, Anne Uyttebroeck
Cancer Immunology, Immunotherapy. 2022-10-01 - 4 citationsAvelumab Dose Selection for Clinical Studies in Pediatric Patients with Solid Tumors.Yulia Vugmeyster, Ana-Marija Grisic, Brigitte Brockhaus, Peter Rueckert, Mary Ruisi
Clinical Pharmacokinetics. 2022-07-01 - 2 citationsLong-term avelumab in advanced non-small-cell lung cancer: summaries andanalyses from JAVELIN Solid Tumor.Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, David Spigel, Howard Safran
Future Oncology. 2022-04-01
Press Mentions
- Investigators Find New Cause of Inherited Predisposition to Blood ClotsMay 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
